Drug recall · February 20, 2019
COSOPT Ophthalmic Solution recall
Why: Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10
- Lots / codes
Lots: 426007 and 426008, exp 4/2020
- Quantity
- 30,794 bottles
- Company
- Akorn Inc, Lake Forest, IL
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- December 20, 2018 · Voluntary: Firm initiated
- Classified
- February 8, 2019
- Reported
- February 20, 2019
- Ended
- November 6, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.